BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28455216)

  • 1. Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.
    Sandstrom TS; Ranganath N; Angel JB
    Cytokine Growth Factor Rev; 2017 Oct; 37():1-16. PubMed ID: 28455216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I IFN--a blunt spear in fighting HIV-1 infection.
    Acchioni C; Marsili G; Perrotti E; Remoli AL; Sgarbanti M; Battistini A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):143-58. PubMed ID: 25466629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of Type I Interferon Induction by HIV Infection of T Cells.
    Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G
    PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between Intrinsic and Innate Immunity during HIV Infection.
    Bergantz L; Subra F; Deprez E; Delelis O; Richetta C
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 evades innate immune recognition through specific cofactor recruitment.
    Rasaiyaah J; Tan CP; Fletcher AJ; Price AJ; Blondeau C; Hilditch L; Jacques DA; Selwood DL; James LC; Noursadeghi M; Towers GJ
    Nature; 2013 Nov; 503(7476):402-405. PubMed ID: 24196705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity against HIV-1 infection.
    Altfeld M; Gale M
    Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.
    Gringhuis SI; Hertoghs N; Kaptein TM; Zijlstra-Willems EM; Sarrami-Forooshani R; Sprokholt JK; van Teijlingen NH; Kootstra NA; Booiman T; van Dort KA; Ribeiro CM; Drewniak A; Geijtenbeek TB
    Nat Immunol; 2017 Feb; 18(2):225-235. PubMed ID: 28024153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon induction by RNA viruses and antagonism by viral pathogens.
    Nan Y; Nan G; Zhang YJ
    Viruses; 2014 Dec; 6(12):4999-5027. PubMed ID: 25514371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV MicroRNA BART16 Suppresses Type I IFN Signaling.
    Hooykaas MJG; van Gent M; Soppe JA; Kruse E; Boer IGJ; van Leenen D; Groot Koerkamp MJA; Holstege FCP; Ressing ME; Wiertz EJHJ; Lebbink RJ
    J Immunol; 2017 May; 198(10):4062-4073. PubMed ID: 28416598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term HIV-1 infection induces an antiviral state in primary macrophages.
    Pujantell M; Badia R; Ramirez C; Puig T; Clotet B; Ballana E; Esté JA; Riveira-Muñoz E
    Antiviral Res; 2016 Sep; 133():145-55. PubMed ID: 27510577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.
    Sugawara S; Thomas DL; Balagopal A
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):25-32. PubMed ID: 29999412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune evasion strategies of DNA and RNA viruses.
    Beachboard DC; Horner SM
    Curr Opin Microbiol; 2016 Aug; 32():113-119. PubMed ID: 27288760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
    Garcia-Vidal E; Castellví M; Pujantell M; Badia R; Jou A; Gomez L; Puig T; Clotet B; Ballana E; Riveira-Muñoz E; Esté JA
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of HIV-1 capsid in viral replication and immune evasion.
    Le Sage V; Mouland AJ; Valiente-Echeverría F
    Virus Res; 2014 Nov; 193():116-29. PubMed ID: 25036886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages.
    Decalf J; Desdouits M; Rodrigues V; Gobert FX; Gentili M; Marques-Ladeira S; Chamontin C; Mougel M; Cunha de Alencar B; Benaroch P
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferon responses are impaired in latently HIV infected cells.
    Ranganath N; Sandstrom TS; Fadel S; Côté SC; Angel JB
    Retrovirology; 2016 Sep; 13(1):66. PubMed ID: 27613235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune interferon responses to human immunodeficiency virus-1 infection.
    Hughes R; Towers G; Noursadeghi M
    Rev Med Virol; 2012 Jul; 22(4):257-66. PubMed ID: 22359246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.
    Tsang J; Chain BM; Miller RF; Webb BL; Barclay W; Towers GJ; Katz DR; Noursadeghi M
    AIDS; 2009 Nov; 23(17):2255-63. PubMed ID: 19741482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
    Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
    J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.